Davenport & Co’s Lantern Pharma LTRN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$81.6K	Hold	25,814	–	–	﹤0.01%	1170
2025 Q1	$91.4K	Hold	25,814	–	–	﹤0.01%	1132
2024 Q4	$82.3K	Sell	25,814 -28,000	-52%	-$89.3K	﹤0.01%	1111
2024 Q3	$197K	Sell	53,814 -10,000	-16%	-$36.7K	﹤0.01%	1084
2024 Q2	$298K	Buy	+63,814	New	+$298K	﹤0.01%	927